About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Atlanta | 13,006 Studies Near You

Clinical TrialsAtlanta

Clinical Trials in Atlanta

Discover 13,006 clinical trials near Atlanta, Georgia. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2081-2100 of 13,006 trials

Active not recruitingStudy of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaThis is a multicenter, randomized, double-blind, controlled Phase 2/3 trial of zanzalintinib in combination with pembrolizumab versus zanzalintinib-matched placebo in combination…NCT06082167·Fullerton, California and 167 others

Find Trials by Condition in Atlanta

Breast Cancerin Atlanta Lung Cancerin Atlanta Prostate Cancerin Atlanta Colorectal Cancerin Atlanta Melanomain Atlanta Leukemiain Atlanta Lymphomain Atlanta Pancreatic Cancerin Atlanta Ovarian Cancerin Atlanta Brain Cancerin Atlanta Diabetes

Data from ClinicalTrials.govTerms

CompletedSafety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell LymphomaThe purpose of this study is to evaluate the safety, PK and efficacy of RP6530, a dual PI3K delta/gamma inhibitor in patients with relapsed and refractory T-cell Lymphoma.NCT02567656·Duarte, California and 7 others

RecruitingA Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerThis study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer.NCT05253651·Glendale, Arizona and 365 others

TerminatedA Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive DisorderThe study will evaluate the efficacy, safety, and tolerability of 450 milligrams (mg) of Rapastinel, compared to placebo in adult patients with major depressive disorder (MDD) who…NCT03352453·Birmingham, Alabama and 16 others

CompletedThe Effect of Dopamine on Diabetic RetinopathyThe purpose of this study is to evaluate the use of electroretinogram (ERG) using a novel handheld system, RETeval, and evaluate contrast sensitivity testing in detecting…NCT02706977·Atlanta, Georgia

RecruitingProphylactic Transfusion In Pregnant in Women With Sickle Cell DiseaseThe goal of this study is to determine if there is a positive effect of prophylactic red blood cell (RBC) transfusion of leukoreduced, ABO, Rh (D/Cc/Ee) and Kell matched blood…NCT06979492·Atlanta, Georgia

RecruitingPre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal CarcinomaThis phase II trial tests how well atezolizumab works in treating patients with human papillomavirus (HPV) related oropharyngeal squamous cell carcinoma that is able to be removed…NCT06254911·Atlanta, Georgia

TerminatedKZR-261 in Subjects With Advanced Solid MalignanciesA first-in-human, open-label, multicenter, Phase 1 study of KZR-261 designed to assess the safety and tolerability, preliminary anti-tumor activity, and pharmacokinetics (PK) of…NCT05047536·Los Angeles, California and 11 others

CompletedImproving Health-Promoting Behaviors in Adolescent Cancer Survivors Using AWAKE: A Feasibility TrialA behavioral intervention called Achieving Wellness After Kancer in Early Life (AWAKE) focused on increasing hope in order to improve quality of life and health-promoting…NCT03564587·Atlanta, Georgia

Active not recruitingTHE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation StudyTo collect information about treatment for severe Aortic Regurgitation (AR), which affects the aortic valve in the heart.NCT02732704·Los Angeles, California and 18 others

CompletedA Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital CytomegalovirusThis is a Phase 1 single-arm open-label study of letermovir in neonates with symptomatic congenital Cytomegalovirus (CMV) disease. There will be two groups enrolled.NCT06118515·Birmingham, Alabama and 2 others

CompletedComparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive DeclineThe purpose of this study was to support the optimal use of rivastigmine patch in long-term treatment of Alzheimer's Disease in patients demonstrating functional and cognitive…NCT00506415·Birmingham, Alabama and 144 others

CompletedAntiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSMThe study seeks to understand how anti-HIV drug Biktarvy, which contains the drugs tenofovir alafenamide (TAF), emtricitabine (FTC), and bictegravir (BIC) is absorbed and how long…NCT04039217·Atlanta, Georgia

WithdrawnA Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALSArimoclomol is a small molecule that upregulates "molecular chaperones" in cells under stress.NCT00561366·Pacific Palisades, California and 34 others

CompletedA Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaThe purpose of this study is to evaluate the efficacy of daratumumab in addition to standard chemotherapy in pediatric participants with relapsed/refractory B-cell acute…NCT03384654·Birmingham, Alabama and 52 others

Active not recruitingTesting Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP TrialThis phase III trial studies how well pembrolizumab works compared to standard of care observation in treating patients with stage I-III Merkel cell cancer that has been…NCT03712605·Birmingham, Alabama and 551 others

CompletedPRediction of Opioid-induced Respiratory Depression In Patients Monitored by capnoGraphYPRODIGY is a prospective, multi-center, post-market, international cohort study.NCT02811302·Aurora, Colorado and 15 others

TerminatedMinimize Menorrhagia in Women With Von Willebrand DiseaseThis is an outpatient, 24-week Phase III prospective, randomized, crossover trial comparing recombinant von Willebrand factor (rVWF) and tranexamic acid (TA, Lysteda®) to minimize…NCT02606045·Gilbert, Arizona and 18 others

Active not recruitingIbrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin LymphomaThis phase II trial studies how well ibrutinib and nivolumab work in treating patients with classical Hodgkin lymphoma that has come back or has not responded to treatment.NCT02940301·Atlanta, Georgia and 1 other

CompletedStudy to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)The study is conducted to assess the efficacy of real-time CGM data in preventing hypoglycemia in patients with type 2 diabetes and end-stage kidney disease (ESKD), treated with…NCT04473430·Atlanta, Georgia and 1 other

PreviousPage 105 of 651Next

in Atlanta

Heart Diseasein Atlanta